Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,028 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy.
Kadoya M, Hida A, Hashimoto Maeda M, Taira K, Ikenaga C, Uchio N, Kubota A, Kaida K, Miwa Y, Kurasawa K, Shimada H, Sonoo M, Chiba A, Shiio Y, Uesaka Y, Sakurai Y, Izumi T, Inoue M, Kwak S, Tsuji S, Shimizu J. Kadoya M, et al. Among authors: shimizu j. Neurol Neuroimmunol Neuroinflamm. 2016 Oct 7;3(6):e290. doi: 10.1212/NXI.0000000000000290. eCollection 2016 Dec. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27761483 Free PMC article.
Inflammatory myopathy with myasthenia gravis: Thymoma association and polymyositis pathology.
Uchio N, Taira K, Ikenaga C, Kadoya M, Unuma A, Yoshida K, Nakatani-Enomoto S, Hatanaka Y, Sakurai Y, Shiio Y, Kaida K, Kubota A, Toda T, Shimizu J. Uchio N, et al. Among authors: shimizu j. Neurol Neuroimmunol Neuroinflamm. 2018 Dec 24;6(2):e535. doi: 10.1212/NXI.0000000000000535. eCollection 2019 Mar. Neurol Neuroimmunol Neuroinflamm. 2018. PMID: 30697585 Free PMC article.
Anti-TIF1-γ antibody and cancer-associated myositis: A clinicohistopathologic study.
Hida A, Yamashita T, Hosono Y, Inoue M, Kaida K, Kadoya M, Miwa Y, Yajima N, Maezawa R, Arai S, Kurasawa K, Ito K, Shimada H, Iwanami T, Sonoo M, Hatanaka Y, Murayama S, Uchibori A, Chiba A, Aizawa H, Momoo T, Nakae Y, Sakurai Y, Shiio Y, Hashida H, Yoshizawa T, Sakiyama Y, Oda A, Inoue K, Takeuchi S, Iwata NK, Date H, Masuda N, Mikata T, Motoyoshi Y, Uesaka Y, Maeda MH, Nakashima R, Tsuji S, Kwak S, Mimori T, Shimizu J. Hida A, et al. Among authors: shimizu j. Neurology. 2016 Jul 19;87(3):299-308. doi: 10.1212/WNL.0000000000002863. Epub 2016 Jun 24. Neurology. 2016. PMID: 27343066
Clinicopathologic features of myositis patients with CD8-MHC-1 complex pathology.
Ikenaga C, Kubota A, Kadoya M, Taira K, Uchio N, Hida A, Maeda MH, Nagashima Y, Ishiura H, Kaida K, Goto J, Tsuji S, Shimizu J. Ikenaga C, et al. Among authors: shimizu j. Neurology. 2017 Sep 5;89(10):1060-1068. doi: 10.1212/WNL.0000000000004333. Epub 2017 Aug 9. Neurology. 2017. PMID: 28794251
Alanine transaminase is predominantly increased in the active phase of anti-HMGCR myopathy.
Kubota A, Shimizu J, Unuma A, Maeda M, Shirota Y, Kadoya M, Uchio N, Sakiyama Y, Arai N, Shiio Y, Uesaka Y, Hashida H, Iwata NK, Goto J, Nakashima R, Mimori T, Toda T. Kubota A, et al. Among authors: shimizu j. Neuromuscul Disord. 2022 Jan;32(1):25-32. doi: 10.1016/j.nmd.2021.10.007. Epub 2021 Oct 28. Neuromuscul Disord. 2022. PMID: 34916121
IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay.
Kadoya M, Kaida K, Koike H, Takazaki H, Ogata H, Moriguchi K, Shimizu J, Nagata E, Takizawa S, Chiba A, Yamasaki R, Kira JI, Sobue G, Ikewaki K. Kadoya M, et al. Among authors: shimizu j. J Neuroimmunol. 2016 Dec 15;301:16-22. doi: 10.1016/j.jneuroim.2016.10.013. Epub 2016 Nov 9. J Neuroimmunol. 2016. PMID: 27852440
1,028 results